Journal of Global Infectious DiseasesOfficial Publishing of INDUSEM and OPUS 12 Foundation, Inc. Users online:202  
Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size     
Home About us Editors Ahead of Print Current Issue Archives Search Instructions Subscribe Advertise Login 
 
This article has been cited by
1Targeting soluble proteins to exosomes using a ubiquitin tag
Yong Cheng,Jeffery S. Schorey
Biotechnology and Bioengineering.2016;113(6)1315
[DOI]
2Vaccinations in children on immunosuppressive medications for renal disease
Sushmita Banerjee,Pathum Vindana Dissanayake,Asiri Samantha Abeyagunawardena
Pediatric Nephrology.2016;31(9)1437
[DOI]
3Combined use of live-attenuated and inactivated influenza vaccines to enhance heterosubtypic protection
Li-Meng Yan,Olive T.W. Li,Chek M. Poh,Ranawaka A.P.M. Perera,Sophie A. Valkenburg,Malik Peiris,Leo L.M. Poon
Virology.2018;525(9)73
[DOI]
4Lectins as mitosis stimulating factors: Briefly reviewed
Elba V.M.M. Carvalho,Weslley F. Oliveira,Luana C.B.B. Coelho,Maria T.S. Correia
Life Sciences.2018;207(9)152
[DOI]
5Evaluation of aqueous extracts of Cistanche deserticola as a polysaccharide adjuvant for seasonal influenza vaccine in young adult mice
Bin Zhao,Jun Lian,Danyang Wang,Quanxiao Li,Shuangshuang Feng,Jinyao Li,Ailian Zhang
Immunology Letters.2019;213(9)1
[DOI]
6Evaluation of aqueous extracts of Cistanche deserticola as a polysaccharide adjuvant for seasonal influenza vaccine in young adult mice
Ajab Khan,Anam Ahsan,Muhammad Asim Farooq,Mirza Muhammad Faran Ashraf Baig,Qurat-ul-ain Aslam
Immunology Letters.2020;213(9)167
[DOI]
7Incorporation of a Novel CD4+ Helper Epitope Identified from Aquifex aeolicus Enhances Humoral Responses Induced by DNA and Protein Vaccinations
Ziyang Xu,Neethu Chokkalingam,Edgar Tello-Ruiz,Susanne Walker,Daniel W. Kulp,David B. Weiner
iScience.2020;23(8)101399
[DOI]
8Immunoinformatics design of a novel multi-epitope peptide vaccine to combat multi-drug resistant infections caused by Vibrio vulnificus
Ghulam Abbas,Iqra Zafar,Sajjad Ahmad,Syed Sikander Azam
European Journal of Pharmaceutical Sciences.2020;142(8)105160
[DOI]
9A COVID-19 vaccine—dare to dream
Alison Phillis
British Journal of Community Nursing.2020;25(12)2
[DOI]
10Perspectives in Peptide-Based Vaccination Strategies for Syndrome Coronavirus 2 Pandemic
Concetta Di Natale,Sara La Manna,Ilaria De Benedictis,Paola Brandi,Daniela Marasco
Frontiers in Pharmacology.2020;11(12)2
[DOI]
11Toxicological Effects of Nickel Chloride on IgA+ B Cells and sIgA, IgA, IgG, IgM in the Intestinal Mucosal Immunity in Broilers
Bangyuan Wu,Hengmin Cui,Xi Peng,Jing Fang,Zhicai Zuo,Junliang Deng,Jianying Huang
International Journal of Environmental Research and Public Health.2014;11(8)8175
[DOI]
12COVID-19 Vaccines: A Race Against Time in the Middle of Death and Devastation!
Mohammad S. Khuroo,Mohammad Khuroo,Mehnaaz S. Khuroo,Ahmad A. Sofi,Naira S. Khuroo
Journal of Clinical and Experimental Hepatology.2020;10(6)610
[DOI]
13Designing the Next Generation of Vaccines: Relevance for Future Pandemics
Jorge Domínguez-Andrés,Reinout van Crevel,Maziar Divangahi,Mihai G. Netea,Vinayaka R. Prasad
mBio.2020;11(6)610
[DOI]
14Overview of computational vaccinology: vaccine development through information technology
Nishita Vaishnav,Aparna Gupta,Sneha Paul,Georrge J. John
Journal of Applied Genetics.2015;56(3)381
[DOI]
15The ongoing evolution of antibody-based treatments for Ebola virus infection
Emelissa J Mendoza,Trina Racine,Gary P Kobinger
Immunotherapy.2017;9(5)435
[DOI]
16The ongoing evolution of antibody-based treatments for Ebola virus infection
Miguel Betancourt-Cravioto,Jorge Abelardo Falcón-Lezama,Roberto Tapia-Conyer
Immunotherapy.2017;9(5)435
[DOI]
17Microneedle arrays for vaccine delivery: the possibilities, challenges and use of nanoparticles as a combinatorial approach for enhanced vaccine immunogenicity
Aoife Maria Rodgers,Ana Sara Cordeiro,Adrien Kissenpfennig,Ryan F Donnelly
Expert Opinion on Drug Delivery.2018;15(9)851
[DOI]
18Single-injection vaccines: Progress, challenges, and opportunities
Kevin J. McHugh,Rohiverth Guarecuco,Robert Langer,Ana Jaklenec
Journal of Controlled Release.2015;219(9)596
[DOI]
19Vi-Vaccinations Induce Heterogeneous Plasma Cell Responses That Associate With Protection From Typhoid Fever
Deborah L. Cross,Marije K. Verheul,Michael D. Leipold,Gerlinde Obermoser,Celina Jin,Elizabeth Jones,Joshua S. Starr,Irina Mohorianu,Christoph J. Blohmke,Holden T. Maecker,Giorgio Napolitani,Jennifer Hill,Andrew J. Pollard
Frontiers in Immunology.2020;11(9)596
[DOI]
20Immune Ecosystem of Virus-Infected Host Tissues
Mohamed Maarouf,Kul Rai,Mohsan Goraya,Ji-Long Chen
International Journal of Molecular Sciences.2018;19(5)1379
[DOI]
21Vaccines and disease-modifying treatments
Emmanuelle Waubant,Gavin Giovannoni,Chris Hawkes,Michael Levy
Multiple Sclerosis and Related Disorders.2018;26(5)A1
[DOI]
22An evaluation of different classification algorithms for protein sequence-based reverse vaccinology prediction
Ashley I. Heinson,Rob M. Ewing,John W. Holloway,Christopher H. Woelk,Mahesan Niranjan,Alexandre G. de Brevern
PLOS ONE.2019;14(12)e0226256
[DOI]
23Antimicrobial Resistance: A Tale of Nasty Enemies and Powerful Weapons
Fabiola Vacca,Dario Cardamone,Marco Troisi,Claudia Sala,Rino Rappuoli
Frontiers for Young Minds.2020;8(12)e0226256
[DOI]
24High antibody titres induced by protein subunit vaccines using Mycobacterium ulcerans antigens Hsp18 and MUL_3720 with a TLR-2 agonist fail to protect against Buruli ulcer in mice
Kirstie M. Mangas,Nicholas J. Tobias,Estelle Marion,Jérémie Babonneau,Laurent Marsollier,Jessica L. Porter,Sacha J. Pidot,Chinn Yi Wong,David C. Jackson,Brendon Y. Chua,Timothy P. Stinear
PeerJ.2020;8(12)e9659
[DOI]
25Crimean-Congo haemorrhagic fever virus: Past, present and future insights for animal modelling and medical countermeasures
E. J. Mendoza,B. Warner,D. Safronetz,C. Ranadheera
Zoonoses and Public Health.2018;65(5)465
[DOI]
26Crimean-Congo haemorrhagic fever virus: Past, present and future insights for animal modelling and medical countermeasures
Rie S. Kallerup,Camilla Foged
Zoonoses and Public Health.2015;65(5)15
[DOI]
27An Overview of History, Evolution, and Manufacturing of Various Generations of Vaccines
Alireza Tahamtan,Javad Charostad,Seyyed Javad Hoseini Shokouh,Mohammad Barati
Journal of Archives in Military Medicine.2017;In Press(In Press)15
[DOI]
28Enfeksiyöz Nekrotik Hepatitis Asisinin Üretiminde Poli (D, L-Laktik-Ko-Glikolik Asit) (PLGA) Biyopolimerinin Adjuvant Etkisinin Arastirilmasi
Zehra AKINCI,Hakan KALENDER
Etlik Veteriner Mikrobiyoloji Dergisi.2019;30(1)70
[DOI]
29Particulate inorganic adjuvants: recent developments and future outlook
Charlotte N. Maughan,Stephen G. Preston,Gareth R. Williams
Journal of Pharmacy and Pharmacology.2015;67(3)426
[DOI]
30Immune Response to Vaccination in Patients with Psoriasis Treated with Systemic Therapies
Andrea Chiricozzi,Paolo Gisondi,Francesco Bellinato,Giampiero Girolomoni
Vaccines.2020;8(4)769
[DOI]
31Baited vaccines: A strategy to mitigate rodent-borne viral zoonoses in humans
Emelissa J. Mendoza,Bryce Warner,Gary Kobinger,Nicholas H. Ogden,David Safronetz
Zoonoses and Public Health.2018;65(6)711
[DOI]
32COVID-19 Vaccine: Critical Questions with Complicated Answers
Mohammad Faisal Haidere,Zubair Ahmed Ratan,Senjuti Nowroz,Sojib Bin Zaman,You-Jung Jung,Hassan Hosseinzadeh,Jae Youl Cho
Biomolecules & Therapeutics.2021;29(1)1
[DOI]
33Lentiviral Protein Transfer Vectors Are an Efficient Vaccine Platform and Induce a Strong Antigen-Specific Cytotoxic T Cell Response
Katharina M. Uhlig,Stefan Schülke,Vivian A. M. Scheuplein,Anna H. Malczyk,Johannes Reusch,Stefanie Kugelmann,Anke Muth,Vivian Koch,Stefan Hutzler,Bianca S. Bodmer,Axel Schambach,Christian J. Buchholz,Zoe Waibler,Stephan Scheurer,Michael D. Mühlebach,F. Kirchhoff
Journal of Virology.2015;89(17)9044
[DOI]
34Lentiviral Protein Transfer Vectors Are an Efficient Vaccine Platform and Induce a Strong Antigen-Specific Cytotoxic T Cell Response
Xinlan Yang
Journal of Virology.2020;89(17)289
[DOI]
35Scrutinizing MHC-I Binding Peptides and Their Limits of Variation
Christian P. Koch,Anna M. Perna,Max Pillong,Nickolay K. Todoroff,Paul Wrede,Gerd Folkers,Jan A. Hiss,Gisbert Schneider,James M. Briggs
PLoS Computational Biology.2013;9(6)e1003088
[DOI]
36Understanding modern-day vaccines: what you need to know
Volker Vetter,Gülhan Denizer,Leonard R. Friedland,Jyothsna Krishnan,Marla Shapiro
Annals of Medicine.2018;50(2)110
[DOI]
37Fabrication and Characterization of Tumor Nano-Lysate as a Preventative Vaccine for Breast Cancer
Jenna A. Dombroski,Nidhi Jyotsana,Davis W. Crews,Zhenjiang Zhang,Michael R. King
Langmuir.2020;36(23)6531
[DOI]
38Nanocarrier Vaccines for SARS-CoV-2
Jatin Machhi,Farah Shahjin,Srijanee Das,Milankumar Patel,Mai Mohamed Abdelmoaty,Jacob D. Cohen,Preet Amol Singh,Ashish Baldi,Neha Bajwa,Raj Kumar,Lalit K. Vora,Tapan A. Patel,Maxim D. Oleynikov,Dhruvkumar Soni,Pravin Yeapuri,Insiya Mukadam,Rajashree Chakraborty,Caroline G. Saksena,Jonathan Herskovitz,Mahmudul Hasan,David Oupicky,Suvarthi Das,Ryan F. Donnelly,Kenneth S. Hettie,Linda Chang,Howard E. Gendelman,Bhavesh D. Kevadiya
Advanced Drug Delivery Reviews.2021;36(23)6531
[DOI]
39Coronavirus Disease 2019 (COVID-19) Spread and Pharmacovigilance Implications: Expert Opinion
Peter Yamoah,Thelma Mpoku Alalbila,Varsha Bangalee,Frasia Oosthuizen
Therapeutic Innovation & Regulatory Science.2020;54(6)1359
[DOI]
40Effectiveness of formalin-killed vaccines containing CpG oligodeoxynucleotide 1668 adjuvants against Vibrio harveyi in orange-spotted grouper
Hai Trong Nguyen,Thuy Thi Thu Nguyen,Yi-Ting Wang,Pei-Chyi Wang,Shih-Chu Chen
Fish & Shellfish Immunology.2017;68(6)124
[DOI]
41Effects of different cytokines on immune responses of rainbow trout in a virus DNA vaccination model
Yongsheng Cao,Qiya Zhang,Liming Xu,Shaowu Li,Di Wang,Jingzhuang Zhao,Hongbai Liu,Jian Feng,Tongyan Lu
Oncotarget.2017;8(68)112222
[DOI]
42Combating tigecycline resistant Acinetobacter baumannii: A leap forward towards multi-epitope based vaccine discovery
Sajjad Ahmad,Kara E. Ranaghan,Syed Sikander Azam
European Journal of Pharmaceutical Sciences.2019;132(68)1
[DOI]
43Assessing the Importance of Domestic Vaccine Manufacturing Centers: An Overview of Immunization Programs, Vaccine Manufacture, and Distribution
Emma Rey-Jurado,Felipe Tapia,Natalia Muñoz-Durango,Margarita K. Lay,Leandro J. Carreño,Claudia A. Riedel,Susan M. Bueno,Yvonne Genzel,Alexis M. Kalergis
Frontiers in Immunology.2018;9(68)1
[DOI]
44Computer-aided prediction of antigen presenting cell modulators for designing peptide-based vaccine adjuvants
Gandharva Nagpal,Kumardeep Chaudhary,Piyush Agrawal,Gajendra P. S. Raghava
Journal of Translational Medicine.2018;16(1)1
[DOI]
45Effects of Methionine Deficiency on the B Lymphocyte and Immunoglobulins of Cecal Tonsil in Cobb Broilers
M Zhu,T Ruan,Q Zeng,B Wu
Brazilian Journal of Poultry Science.2019;21(4)1
[DOI]
46Vaccination in Atherosclerosis
Felix Sebastian Nettersheim,Lauren De Vore,Holger Winkels
Cells.2020;9(12)2560
[DOI]
47Alterations in the Human Plasma Lipidome in Response to Tularemia Vaccination
Kristal M. Maner-Smith,Johannes B. Goll,Manoj Khadka,Travis L. Jensen,Jennifer K. Colucci,Casey E. Gelber,Carolyn J. Albert,Steven E. Bosinger,Jacob D. Franke,Muktha Natrajan,Nadine Rouphael,Robert A. Johnson,Patrick Sanz,Evan J. Anderson,Daniel F. Hoft,Mark J. Mulligan,David A. Ford,Eric A. Ortlund
Vaccines.2020;8(3)414
[DOI]
48Current trends in targeted therapy for drug-resistant infections
Leila Rahbarnia,Safar Farajnia,Behrooz Naghili,Vahideh Ahmadzadeh,Kamal Veisi,Roghayyeh Baghban,Sayna Toraby
Applied Microbiology and Biotechnology.2019;103(20)8301
[DOI]
49Convalescent plasma therapy: a promising coronavirus disease 2019 treatment strategy
Ravikant Piyush,Keshav Rajarshi,Rajni Khan,Shashikant Ray
Open Biology.2020;10(9)200174
[DOI]
50Impact of Microbiota: A Paradigm for Evolving Herd Immunity against Viral Diseases
Asha Shelly,Priya Gupta,Rahul Ahuja,Sudeepa Srichandan,Jairam Meena,Tanmay Majumdar
Viruses.2020;12(10)1150
[DOI]
51Vaccination in Multiple Myeloma: Review of Current Literature
Andinet Alemu,John O. Richards,Martin K. Oaks,Michael A. Thompson
Clinical Lymphoma Myeloma and Leukemia.2016;16(9)495
[DOI]
52Stimuli-Responsive Biomaterials for Vaccines and Immunotherapeutic Applications
Noah Pacifici,Amir Bolandparvaz,Jamal S. Lewis
Advanced Therapeutics.2020;3(11)2000129
[DOI]
53Lymphatic targeting by albumin-hitchhiking: Applications and optimisation
Mohammad Abdallah,Olivia O. Müllertz,Ian K. Styles,Alexander Mörsdorf,John F. Quinn,Michael R. Whittaker,Natalie L. Trevaskis
Journal of Controlled Release.2020;327(11)117
[DOI]
54Toll-like receptors as a therapeutic target in cancer, infections and inflammatory diseases
Lizdany Flórez-Álvarez,Lanie Ruiz-Perez,Natalia Taborda,Juan C Hernandez
Immunotherapy.2020;12(5)311
[DOI]
55Chilean aquaculture and the new challenges: Pathogens, immune response, vaccination and fish diversification
C. Flores-Kossack,R. Montero,B. Köllner,K. Maisey
Fish & Shellfish Immunology.2020;98(5)52
[DOI]
56COVID-19 and Multiple Sclerosis: Predisposition and Precautions in Treatment
Shaghayegh Sadeghmousavi,Nima Rezaei
SN Comprehensive Clinical Medicine.2020;2(10)1802
[DOI]
57COVID-19 and Multiple Sclerosis: Predisposition and Precautions in Treatment
Mariette Sourial,Dana Strachan
SN Comprehensive Clinical Medicine.2017;2(10)1802
[DOI]
58Positive affect and peripheral inflammatory markers among adults: A narrative review
Dusti R. Jones,Jennifer E. Graham-Engeland
Psychoneuroendocrinology.2021;123(10)104892
[DOI]
59Emerging Concepts and Technologies in Vaccine Development
Morgan Brisse,Sophia M. Vrba,Natalie Kirk,Yuying Liang,Hinh Ly
Frontiers in Immunology.2020;11(10)104892
[DOI]
60Emerging Concepts and Technologies in Vaccine Development
Mahsa Keshavarz-Fathi,Nima Rezaei
Frontiers in Immunology.2019;11(10)45
[DOI]
61Emerging Concepts and Technologies in Vaccine Development
Letitia D. Jones,Amelia B. Thompson,M. Anthony Moody
Frontiers in Immunology.2019;11(10)167
[DOI]
62Virus-based nanoparticles as platform technologies for modern vaccines
Karin L. Lee,Richard M. Twyman,Steven Fiering,Nicole F. Steinmetz
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology.2016;8(4)554
[DOI]
63Effects of MS disease-modifying therapies on responses to vaccinations: A review.
John Robert Ciotti,Manouela V. Valtcheva,Anne Haney Cross
Multiple Sclerosis and Related Disorders.2020;45(4)102439
[DOI]
64Macrophage-derived insulin-like growth factor-1 affects influenza vaccine efficacy through the regulation of immune cell homeostasis
Il-Sub Yoon,Hyelim Park,Hye-Won Kwak,Yong Woo Jung,Jae-Hwan Nam
Vaccine.2017;35(36)4687
[DOI]
65Comprehensive Analysis of the Safety Profile of a Single-Stranded RNA Nano-Structure Adjuvant
Hyeong-Jun Park,Hae Li Ko,Dong-Hoon Won,Da-Bin Hwang,Yoo-Sub Shin,Hye-Won Kwak,Hye-Jung Kim,Jun-Won Yun,Jae-Hwan Nam
Pharmaceutics.2019;11(9)464
[DOI]
66Biomaterials as Tools to Decode Immunity
Haleigh B. Eppler,Christopher M. Jewell
Advanced Materials.2020;32(13)1903367
[DOI]
67

Convalescent Plasma Therapy for Management of COVID-19: Perspectives and Deployment in the Current Global Pandemic

Nandeeta Samad,Temitayo Eniola Sodunke,Hasan Al Banna,Ashmita Sapkota,Aneeka Nawar Fatema,Katia Iskandar,Dilshad Jahan,Timothy Craig Hardcastle,Tanzina Nusrat,Tajkera Sultana Chowdhury,Mainul Haque
Risk Management and Healthcare Policy.2020;Volume 13(13)2707
[DOI]
68In-silico structural modeling and epitope prediction of highly conserved Plasmodium falciparum protein AMR1
Bijara Devi Sanasam,Sanjeev Kumar
Molecular Immunology.2019;116(13)131
[DOI]
69In-silico structural modeling and epitope prediction of highly conserved Plasmodium falciparum protein AMR1
Bruna dos Santos Rodrigues,Sushant Lakkadwala,Divya Sharma,Jagdish Singh
Molecular Immunology.2019;116(13)515
[DOI]
70Narrative Review on Health-EDRM Primary Prevention Measures for Vector-Borne Diseases
Emily Chan,Tiffany Sham,Tayyab Shahzada,Caroline Dubois,Zhe Huang,Sida Liu,Kevin Hung,Shelly Tse,Kin Kwok,Pui-Hong Chung,Ryoma Kayano,Rajib Shaw
International Journal of Environmental Research and Public Health.2020;17(16)5981
[DOI]
  Addresses 
  My Preferences 


JGID
What's new
Forthcoming Symposia
Submit articles
Email alerts
Join us
Most popular articles
Recommend this journal
Sitemap | What's New | Feedback | Copyright and Disclaimer | Contact Us
© 2008 Journal of Global Infectious Diseases | Published by Wolters Kluwer - Medknow
Online since 10th December, 2008